PLoS Computational BiologyImmunologyPeer-reviewed journal article
Clonal heterogeneity and antigenic stimulation shape persistence of the latent reservoir of HIV
Marco Garcia Noceda, Gargi M. KheriD, Shikhar UttamiD, John P. BartoniD
Abstract
Drug treatment can control HIV-1 replication, but it cannot cure infection. This is because of a long-lived population of quiescent infected cells, known as the latent reservoir (LR), that can restart active replication even after decades of successful drug treatment. Many cells in the LR belong to highly expanded clones, but the processes underlying the clonal structure of the LR are unclear. Understanding the dynamics of the LR and the keys to its persistence is critical for developing an HIV-1 cure. Here we develop a quantitative model of LR dynamics that fits available patient data over time scales spanning from days to decades. We show that the interplay between antigenic stimulation and clonal heterogeneity shapes the dynamics of the LR. In particular, we find that large clones play a central role in long-term persistence, even though they rarely reactivate. Our results could inform the development of HIV-1 cure strategies.
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 16th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The dynamics of the HIV-1 latent reservoir - considering the heterogeneous subpopulations
- Antigen responsive CD4+ T cell clones contribute to the HIV-1 latent reservoir
P. Mendoza, J. R. Jackson, … L. B. Cohn·bioRxiv·Jan 10, 2020
- Models of increased latent HIV reservoir turnover prior to cART initiation imply novel clearance strategies
Aditya Jagarapu, Rajveer Mann, … Ryan Zurakowski·bioRxiv·Jun 6, 2021
- Antigen-driven clonal selection shapes the persistence of HIV-1 infected CD4+ T cells in vivo
F. R. Simonetti, H. Zhang, … R. F. Siliciano·bioRxiv·Dec 1, 2020
- Anti-proliferative therapy for HIV cure: a compound interest approach
D. Reeves, E. Duke, … J. Schiffer·bioRxiv·Jul 12, 2016
- The Replication-Competent HIV-1 Latent Reservoir is Primarily Established Near the Time of Therapy Initiation
M.-R. Abrahams, S. B. Joseph, … R. Swanstrom·bioRxiv·Jan 4, 2019